Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael C Haffner

Showing results (41-50 of 169) with videos related to

Pageof 17
Sort By:
Pathogens (Basel, Switzerland)|December 16, 2020
Putative Autoantigen Leiomodin-1 Is Expressed in the Human Brain and in the Membrane Fraction of Newly Formed NeuronsDavid W Nauen, Michael C Haffner, Juyun Kim, et al.
Acta Neuropathologica Communications|June 5, 2014
Increased 5-hydroxymethylcytosine and decreased 5-methylcytosine are indicators of global epigenetic dysregulation in diffuse intrinsic pontine gliomaSama Ahsan, Eric H Raabe, Michael C Haffner, et al.
Nature Reviews. Urology|December 17, 2020
Genomic and phenotypic heterogeneity in prostate cancerMichael C Haffner, Wilbert Zwart, Martine P Roudier, et al.
Biorxiv : the Preprint Server for Biology|December 19, 2025
Armoring STEAP1 CAR T cells with IL-18 potentiates antitumor activity in Ewing sarcomaVipul Bhatia, Annabelle Tsao, Truman Chong, et al.
Histopathology|December 12, 2025
Molecular subtypes of metastatic prostate cancer: from pathophysiology to diagnosisJeanne M Dsouza, Erolcan Sayar, Michael T Schweizer, et al.
Prostate Cancer and Prostatic Diseases|September 27, 2024
Therapeutic implications of homologous repair deficiency testing in patients with prostate cancer (Part 2 of 2)Anthony V Serritella, Amy Taylor, Michael C Haffner, et al.
Science Advances|January 1, 2026
Phenotypic discovery and therapeutic evaluation of an <i>ITGA3B1</i>-targeting antibody-drug conjugate for bladder cancerJunghyeon Lee, Hyeryeon Jung, Eunhee G Kim, et al.
Endocrinology|May 27, 2006
Characterization of the nuclear factor-kappa B responsiveness of the human dio2 geneAnikó Zeöld, Márton Doleschall, Michael C Haffner, et al.
Prostate Cancer and Prostatic Diseases|October 1, 2024
Germline and somatic testing for homologous repair deficiency in patients with prostate cancer (part 1 of 2)Andrew J Armstrong, Amy Taylor, Michael C Haffner, et al.
The American Journal of Pathology|September 10, 2019
Lactoferrin CpG Island Hypermethylation and Decoupling of mRNA and Protein Expression in the Early Stages of Prostate CarcinogenesisCorey M Porter, Michael C Haffner, Ibrahim Kulac, et al.
Pageof 17

Showing results (41-50 of 169) with videos related to

Sort By:
Pageof 17
Pathogens (Basel, Switzerland)|December 16, 2020
Putative Autoantigen Leiomodin-1 Is Expressed in the Human Brain and in the Membrane Fraction of Newly Formed NeuronsDavid W Nauen, Michael C Haffner, Juyun Kim, et al.
Acta Neuropathologica Communications|June 5, 2014
Increased 5-hydroxymethylcytosine and decreased 5-methylcytosine are indicators of global epigenetic dysregulation in diffuse intrinsic pontine gliomaSama Ahsan, Eric H Raabe, Michael C Haffner, et al.
Nature Reviews. Urology|December 17, 2020
Genomic and phenotypic heterogeneity in prostate cancerMichael C Haffner, Wilbert Zwart, Martine P Roudier, et al.
Biorxiv : the Preprint Server for Biology|December 19, 2025
Armoring STEAP1 CAR T cells with IL-18 potentiates antitumor activity in Ewing sarcomaVipul Bhatia, Annabelle Tsao, Truman Chong, et al.
Histopathology|December 12, 2025
Molecular subtypes of metastatic prostate cancer: from pathophysiology to diagnosisJeanne M Dsouza, Erolcan Sayar, Michael T Schweizer, et al.
Prostate Cancer and Prostatic Diseases|September 27, 2024
Therapeutic implications of homologous repair deficiency testing in patients with prostate cancer (Part 2 of 2)Anthony V Serritella, Amy Taylor, Michael C Haffner, et al.
Science Advances|January 1, 2026
Phenotypic discovery and therapeutic evaluation of an <i>ITGA3B1</i>-targeting antibody-drug conjugate for bladder cancerJunghyeon Lee, Hyeryeon Jung, Eunhee G Kim, et al.
Endocrinology|May 27, 2006
Characterization of the nuclear factor-kappa B responsiveness of the human dio2 geneAnikó Zeöld, Márton Doleschall, Michael C Haffner, et al.
Prostate Cancer and Prostatic Diseases|October 1, 2024
Germline and somatic testing for homologous repair deficiency in patients with prostate cancer (part 1 of 2)Andrew J Armstrong, Amy Taylor, Michael C Haffner, et al.
The American Journal of Pathology|September 10, 2019
Lactoferrin CpG Island Hypermethylation and Decoupling of mRNA and Protein Expression in the Early Stages of Prostate CarcinogenesisCorey M Porter, Michael C Haffner, Ibrahim Kulac, et al.
Pageof 17